Ensign Peak Advisors, Inc
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,198,672
+$1,716,772 QoQ
Shares Held
97,660
-14.2% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#73
of 275 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. KYMR ranks #29 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in KYMR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,198,672 | 97,660 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,481,900 | 113,842 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,395,607 | 95,047 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,201,370 | 91,897 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,010,385 | 91,897 | Shares | Sole | 2025-08-12 | |
| 2023-12-31 | $1,023,670 | 40,207 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $558,877 | 40,207 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $924,358 | 40,207 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,191,333 | 40,207 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,003,566 | 40,207 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,035,098 | 47,547 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $913,950 | 46,417 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,508,729 | 59,280 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,763,687 | 59,280 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,923,147 | 32,740 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,042,890 | 62,740 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,438,076 | 62,740 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,240,000 | 20,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $646,200 | 20,000 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||